Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|January 19, 2021
Hydatid disease, hepatic injury and hypertonic saline: a clinical conundrumAngus Lane, Hugh Wright
BMJ Case Reports|December 21, 2018
Meropenem-induced liver injury and beta-lactam cross-reactivityTimothy Tattersall, Hugh Wright, Andrew Redmond
Trauma Case Reports|March 21, 2022
Combination of a free vascularised fibula and the Masquelet technique for long bone ulna defect reconstruction: A case reportEdmund Hugh Wright, Grainne Bourke, Peter V Giannoudis
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2019
Health Risks of Flood DisastersDavid L Paterson, Hugh Wright, Patrick N A Harris
Orbit (Amsterdam, Netherlands)|July 26, 2017
Consideration for eliminating conjunctival closure in the enucleation procedureJohn D Pemberton, Hugh Wright, Brian T Fowler, et al.
The Journal of Infection|May 11, 2018
Long-term morbidity and mortality following bloodstream infection: A systematic literature reviewJohn F McNamara, Elda Righi, Hugh Wright, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 24, 2023
Treatment Failure Due to Adaptive Resistance Mechanisms in a Severe and Complicated Bloodstream Infection Due to Elizabethkingia meningosepticaAdam G Stewart, Jason A Roberts, Brian M Forde, et al.
Trials|December 8, 2021
Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trialHugh Wright, Patrick N A Harris, Mark D Chatfield, et al.
Open Forum Infectious Diseases|April 27, 2022
Efficacy and Safety of Carbapenems vs New Antibiotics for Treatment of Adult Patients With Complicated Urinary Tract Infections: A Systematic Review and Meta-analysisYukiko Ezure, Veronica Rico, David L Paterson, et al.
The Lancet. Infectious Diseases|October 9, 2025
Cefiderocol versus standard therapy for hospital-acquired and health-care-associated Gram-negative bacterial bloodstream infection (the GAME CHANGER trial): an open-label, parallel-group, randomised trialDavid L Paterson, Helmi Sulaiman, Po-Yu Liu, et al.
Pageof 1